NASDAQ:PLRX | Free Cash Flow | PLIANT THERAPEUTICS, INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$19.23M$0.00-$19.23M
2025-12-31-$17.79M$0.00-$17.79M
2025-03-31-$48.86M$262,000.00-$49.13M
2024-12-31-$47.66M$209,000.00-$47.87M
2024-03-31-$30.27M$1.49M-$31.76M
2023-12-31-$25.1M$61,000.00-$25.16M
2023-03-31-$30.28M$163,000.00-$30.44M
2022-12-31-$31.24M$166,000.00-$31.41M
2022-03-31-$20.5M$644,000.00-$21.14M
2021-12-31-$19.87M$592,000.00-$20.46M
2021-03-31-$13.67M$242,000.00-$13.91M
2020-12-31-$16.49M$587,000.00-$17.07M
2020-03-31-$12.77M$336,000.00-$13.1M-118.80%
2019-12-31$36.74M$184,000.00$36.56M86.70%

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$128.34M$374,000.00-$128.71M
2024-12-31-$155.5M$3.85M-$159.35M
2023-12-31-$116.36M$921,000.00-$117.28M
2022-12-31-$94.63M$1.76M-$96.39M
2021-12-31-$75.44M$1.95M-$77.4M
2020-12-31-$37.27M$1.53M-$38.8M
2019-12-31-$2.75M$964,000.00-$3.71M